chris kresser glp-1 RHR: The Blind Spot: What Ozempic Won't Do for Your Metabolic Health Chris Kresser, Founder, CEO, President

Learn dietary changes, lifestyle adjustments, when to seek medical advice, and medication options to manage this common side effect effectively whilst continuing your treatment.

we conducted this emulated target trial to evaluate the risk of developing incident PsA in T2DM patients treated with SGLT2i, GLP-1 RA, and DPP-4i.

Learn about the mechanism of action of RYBELSUS (semaglutide) for your adult patients with type 2 diabetes

For more info, please read our ad policy, content principles and vetting policy.

Josh Eloge joins the show to explain how medications like Ozempic and Wegovy may impact anxiety, depression, and overall brain chemistry

Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure.A new Northwestern Medicine study tracked more than 42,000 adul